文献速递关节外科

Exeter Universal骨水泥股骨假体在原始中心外20年生存率、临床与影像学结果

Exeter Universal cemented femoral component.
PubMed 文献 · Bone Joint J · 2020-01-01

在区综合医院对207例患者植入225个Exeter Universal骨水泥股骨假体,前瞻性收集1年、5年及此后每5年的临床与影像学数据,并与国家关节登记和全科医生记录交叉核对失访者。以股骨松动为终点20至22年生存率98.7%(n=220,95%CI 96.1%至100%),以任何原因翻修为终点生存率92.6%(n=209,95%CI 89.4至95.55)。作者结论认为该骨水泥股骨假体在原始中心外植入的长期结果优良。

要点

  • 以股骨松动为终点,20至22年生存率为98.7%(n=220,95%CI 96.1%至100%)。
  • 以任何原因翻修为终点,20至22年生存率为92.6%(n=209,95%CI 89.4至95.55)。
  • 最差情景下(将2例失访计为失败)20至22年总体生存率为91.7%(n=207,95%CI 87.8至95.9)。

核心结论

  • 作者结论认为,在原始中心外植入的Exeter Universal骨水泥股骨假体长期结果优良。

研究设计与样本

  • 在区综合医院开展的队列研究,共225个Exeter Universal骨水泥股骨假体(Stryker,Newbury,英国)植入207例患者。
  • 全部患者行全髋关节置换术,髋臼假体为骨水泥固定(n=215)或非骨水泥固定(n=10)。
  • 临床与影像学数据在前瞻性设定的1年、5年及此后每5年收集。
  • 放射学与临床失访的5例患者与国家关节登记(NJR)数据及全科医生(GP)记录交叉核对,以评估是否因任何原因接受翻修。

主要发现

  • 研究期间144例患者(157髋)死亡(69.78%),2例患者失访,61例患者(66髋)可随访(29.33%)。
  • 225髋中,3髋因股骨失败伴骨溶解行翻修,1髋因假体周围骨折行股骨假体翻修。
  • 8髋仅因松动行髋臼假体翻修,2髋在因髋臼松动翻修时发现两组件均松动(当时无影像学股骨骨溶解)而行双组件翻修。
  • 2例患者因感染行翻修。

关键数值与推荐

  • 以股骨松动为终点,Exeter Universal股骨假体20至22年生存率为98.7%(n=220,95%CI 96.1%至100%)。
  • 以任何原因翻修为终点,20至22年生存率为92.6%(n=209,95%CI 89.4至95.55)。
  • 最差情景下(将2例失访患者计为失败),20至22年总体生存率为91.7%(n=207,95%CI 87.8至95.9)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: We present the results, in terms of survival, clinical outcome, and radiological appearance at 20 years, in a cohort of 225 cemented Exeter Universal femoral components (Stryker, Newbury, UK) implanted in 207 patients, at a district general hospital. METHODS: All patients in this study had a total hip arthroplasty (THA) using an Exeter Universal femoral component with a cemented (n = 215) or cementless (n = 10) acetabular component. Clinical and radiological data were collected prospectively at one year, five years, and every five years thereafter. Patients lost to radiological and clinical follow-up (five) were cross-referenced with National Joint Registry (NJR) data and general practitioner (GP) records to assess whether they had undergone revision for any reason. RESULTS: During this period of study 144 patients (157 hips) died (69.78%). Two patients were lost to follow-up, leaving 61 patients (66 hips) available for review (29.33%). Of the 225 hips, three underwent revision for femoral failure with osteolysis. One underwent femoral component revision for treatment of a periprosthetic fracture. Eight underwent revision of the acetabular component only for loosening. Two hips had both components revised, when components were found to be loose at time of revision for acetabular loosening, though no radiological femoral osteolysis. Two patients underwent revision for infection. Using femoral loosening as an endpoint, the survival of the Exeter Universal femoral component was 98.7% (n = 220, 95% confidence interval (CI) 96.1% to 100%) at 20 to 22 years. Survival with an endpoint of revision for any reason was 92.6% (n = 209, 95% CI 89.4 to 95.55), with a 'worst-case scenario' (considering two patients lost to follow-up to have failed), the overall survival rate was 91.7% (n = 207, 95% CI 87.8 to 95.9) at 20 to 22 years. CONCLUSION: Our results confirm excellent long-term results for the cemented Exeter Universal femoral componentimplanted outside of the originating centre. Cite this article: Bone Joint J 2020;102-B(10):1319-1323.

来源:Bone Joint J,查看原文。版权归原作者所有。

引用

  1. Khatun F, Gill DF, Atrey A, et al. Exeter Universal cemented femoral component. Bone Joint J. 2020. PMID: 32993348. doi:10.1302/0301-620X.102B10.BJJ-2019-1454.R1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。